Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
Forte Biosciences Cash and Short Term Investments (Annual) : 76.96M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 76.96M |
| December 31, 2024 | 58.36M |
| December 31, 2023 | 37.12M |
| December 31, 2022 | 41.10M |
| December 31, 2021 | 42.04M |
| December 31, 2020 | 58.76M |
| Date | Value |
|---|---|
| December 31, 2019 | 6.939M |
| December 31, 2018 | 96.09M |
| December 31, 2017 | 88.72M |
| December 31, 2016 | 31.24M |
| December 31, 2015 | 58.91M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| argenx SE | 4.440B |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Anika Therapeutics, Inc. | 57.48M |
| Savara, Inc. | 235.70M |